White Paper

Overcoming Challenges In AAV And LV Viral Vector Manufacturing: How To Design And Launch A Successful Clinical Trial Manufacturing

By Mathias Kahl, Stephan Bauer, Dr. Daniel Köhler, Dr. Tobias Thom, Rico Hinrichs, Stefan Borutzki, Christina Pospisil, Dr. Rico Schmidt, Erik Arnold, Dr. Thomas Kreisig, IDT Biologika

Scientist Using Pipette GettyImages-1140779660

The cell and gene therapy industry is experiencing rapid growth as new drugs hold the potential to treat and possibly cure a wide range of devastating diseases, including cancer. However, as a number of therapies advance toward clinical trials, drug sponsors are limited in their knowledge of how to design and launch a successful clinical trial manufacturing (CTM) process. In addition to optimizing their CTM process, it is paramount for sponsors to properly understand and implement the investigation and manufacturing of adeno-associated virus vectors (AAVs) and lentiviral vectors (LVVs). Without addressing these factors, sponsors face high costs, delays, and the possibility of failure to bring their drug to patients.

Collaborating with a CDMO with AAV and LVV manufacturing expertise can help you navigate the complex and evolving challenges of viral vector production. A reliable partner with established platform applications can manufacture clinical trial material on rapid timelines and build a process that conserves resources. Utilizing a CDMO’s highly efficient analytical testing capabilities is also crucial to help release your batches for trial faster. Learn more about how finding the right experienced partner can help you leverage the upstream and downstream technologies, analytical testing methods, and formulation strategies best suited for your product.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene